Published in Biochem Biophys Res Commun on April 13, 2000
Delta ribozyme benefits from a good stability in vitro that becomes outstanding in vivo. RNA (2002) 1.13
Ribozyme-based gene-inactivation systems require a fine comprehension of their substrate specificities; the case of delta ribozyme. Curr Med Chem (2003) 1.10
Formation of the P1.1 pseudoknot is critical for both the cleavage activity and substrate specificity of an antigenomic trans-acting hepatitis delta ribozyme. Nucleic Acids Res (2003) 1.00
Cross-linking experiments reveal the presence of novel structural features between a hepatitis delta virus ribozyme and its substrate. RNA (2004) 0.98
Kinetic and binding analysis of the catalytic involvement of ribose moieties of a trans-acting delta ribozyme. J Biol Chem (2002) 0.98
Gene targeting in the Gram-Positive bacterium Lactococcus lactis, using various delta ribozymes. Appl Environ Microbiol (2006) 0.89
Monitoring of an RNA multistep folding pathway by isothermal titration calorimetry. Biophys J (2009) 0.89
A novel structural rearrangement of hepatitis delta virus antigenomic ribozyme. Nucleic Acids Res (2007) 0.88
Antigenomic delta ribozyme variants with mutations in the catalytic core obtained by the in vitro selection method. Nucleic Acids Res (2006) 0.84
Examination of the folding pathway of the antigenomic hepatitis delta virus ribozyme reveals key interactions of the L3 loop. RNA (2006) 0.84
Selection of the most potent specific on/off adaptor-hepatitis delta virus ribozymes for use in gene targeting. Nucleic Acid Ther (2011) 0.76
Evidence for ditopic coordination of phosphate diesters to [Mg(15-crown-5)]2+. Implications for magnesium biocoordination chemistry. J Biol Inorg Chem (2004) 0.75
Compilation and analysis of viroid and viroid-like RNA sequences. Nucleic Acids Res (1996) 2.33
Update of the viroid and viroid-like sequence database: addition of a hepatitis delta virus RNA section. Nucleic Acids Res (1997) 1.76
The RNA of both polarities of the peach latent mosaic viroid self-cleaves in vitro solely by single hammerhead structures. Nucleic Acids Res (1995) 1.51
Mixed DNA/RNA polymers are cleaved by the hammerhead ribozyme. Biochemistry (1990) 1.35
Mapping in solution shows the peach latent mosaic viroid to possess a new pseudoknot in a complex, branched secondary structure. J Virol (2000) 1.25
The viroid and viroid-like RNA database. Nucleic Acids Res (1999) 1.22
The viroid and viroid-like RNA database. Nucleic Acids Res (1998) 1.17
An efficient strategy for the synthesis of circular RNA molecules. Nucleic Acids Res (1995) 1.11
Kinetic analysis of delta ribozyme cleavage. Biochemistry (1998) 1.10
Nucleotides -1 to -4 of hepatitis delta ribozyme substrate increase the specificity of ribozyme cleavage. Antisense Nucleic Acid Drug Dev (2000) 1.10
Substrate specificity of delta ribozyme cleavage. J Biol Chem (1998) 1.09
Peach latent mosaic viroid is locked by a 2',5'-phosphodiester bond produced by in vitro self-ligation. J Mol Biol (1997) 1.00
The database of the smallest known auto-replicable RNA species: viroids and viroid-like RNAs. Nucleic Acids Res (2000) 0.98
Practice patterns of Canadian urologists in benign prostatic hyperplasia and prostate cancer. Canadian Prostate Health Council. J Urol (2000) 0.98
Mutational analysis of the antigenomic trans-acting delta ribozyme: the alterations of the middle nucleotides located on the P1 stem. Nucleic Acids Res (1999) 0.97
Presence of a coordinated metal ion in a trans-acting antigenomic delta ribozyme. Nucleic Acids Res (1999) 0.96
Delta ribozyme has the ability to cleave in transan mRNA. Nucleic Acids Res (1999) 0.95
Sequencing of peach latent mosaic viroid variants from nine North American peach cultivars shows that this RNA folds into a complex secondary structure. Virology (2000) 0.92
Long-term followup of initial Ta grade 1 transitional cell carcinoma of the bladder. J Urol (1999) 0.91
A type II ostertagiasis outbreak in cattle in New Brunswick. Can Vet J (1972) 0.91
Intra- and intermolecular nonenzymatic ligations occur within transcripts derived from the peach latent mosaic viroid. Virology (1995) 0.89
Natural 2',5'-phosphodiester bonds found at the ligation sites of peach latent mosaic viroid. J Virol (2001) 0.88
Characterization of the siRNAs associated with peach latent mosaic viroid infection. Virology (2008) 0.85
Efficacy of finasteride is maintained in patients with benign prostatic hyperplasia treated for 5 years. The North American Finasteride Study Group. Urology (1999) 0.84
Characterization of a chemically synthesized RNA having the sequence of the yeast initiator tRNA(Met). FEBS Lett (1990) 0.84
Molecular features of new Peach Latent Mosaic Viroid variants suggest that recombination may have contributed to the evolution of this infectious RNA. Virology (2006) 0.83
Study of the polymerization step of the rolling circle replication of peach latent mosaic viroid. Arch Virol (2001) 0.81
Kinetic analysis of bimolecular hepatitis delta ribozyme. Methods Enzymol (2001) 0.80
Interrelationships between circulating vitamin D metabolites in normocalciuric and hypercalciuric renal stone formers. Ann Nutr Metab (1985) 0.79
[Perineal retraining in urinary stress incontinence]. Ann Chir (1991) 0.78
On the road to a DNA-protein world. RNA (1995) 0.77
Characterization of stable RNAs from the resected intestinal tissues of individuals with either Crohn's disease or ulcerative colitis. Biochem Cell Biol (1997) 0.77
Influence of dietary calcium on serum 1,25-dihydroxyvitamin D concentrations in renal stone formers. Clin Endocrinol (Oxf) (1984) 0.76
Identification of a Crohn's disease specific transcript with potential as a diagnostic marker. Gut (1998) 0.75
Simple technique for making subcutaneous tunnel in creation of A-V fistula using prosthesis. Urology (1991) 0.75
[Ureteroscopy versus in situ extracorporeal shockwave lithotripsy in the treatment of calculi of the distal ureter]. Prog Urol (1996) 0.75
[Usefulness of intravenous urography in the evaluation of benign prostatic hypertrophy]. J Urol (Paris) (1984) 0.75
[La claviculectomy: a treatment still current]. Union Med Can (1977) 0.75
[Internal urethrotomy]. Union Med Can (1984) 0.75
[Urological problems related to aorto-bifemoral surgery (author's transl)]. J Urol (Paris) (1982) 0.75
[Immediate complications of transurethral resection of the prostate: study of 1000 consecutive cases]. Can J Surg (1988) 0.75
Electromyographic study of bulbocavernosus muscle in 15 patients with postmicturition dribbling. Urology (1985) 0.75
Urinary calculi in pregnancy. Can J Surg (1982) 0.75
[Causes and studies of male sterility in an urban French Canadian population]. Union Med Can (1977) 0.75
Colorectal neoplasm: a rare complication of ureterosigmoidostomy. Can J Surg (1979) 0.75
[Treatment of the acute phase of urinary retention (author's transl)]. J Urol (Paris) (1981) 0.75
Staghorn calculi treated by percutaneous nephrolithotomy: risk factors for recurrence. Urology (1993) 0.75
[Value of the oral calcium loading test in the diagnosis of primary hyperparathyroidism]. Union Med Can (1984) 0.75
Long term follow-up of intravesical Bacillus Calmette-Guerin for the treatment of bladder transitional cell carcinoma. Can J Urol (2000) 0.75
Evidence for a model ancestral viroid. Nucleic Acids Symp Ser (1995) 0.75
[Haemorrhage from an ileal loop bladder secondary to portal hypertension (author's transl)]. J Urol (Paris) (1982) 0.75
A Canadian isolate of hepatitis D (delta) virus. Can J Gastroenterol (2000) 0.75